Pseudocirrhosis due to liver metastasis from lung adenocarcinoma. Issue 17 (17th July 2021)

• Record Type: Journal Article
• Authors: Shijubou, Naoki; Sumi, Toshiyuki; Keira, Yoshiko; Shiraishi, Hideaki; Nagahisa, Yuta; Matsuura, Keigo; Sekikawa, Motoki; Yamada, Yuichi; Nakata, Hisashi; Chiba, Hirofumi
• Is Part Of: Thoracic cancer. Volume 12:Issue 17(2021)
• Page Start: 2407
• Page End: 2410
• Publication Date: 2021-07-17
• Subjects: adenocarcinoma -- liver metastasis -- lung cancer -- pseudocirrhosis; Chest -- Cancer -- Periodicals; Chest -- Cancer -- Treatment -- Periodicals; Chest -- Surgery -- Periodicals; 616.99494005
• DOI: 10.1111/1759-7714.14084
• Languages: English
• ISSNs: 1759-7706

Abstract

Abstract: Pseudocirrhosis is a radiological diagnosis of cirrhosis without histological evidence and occurs as a complication of liver metastases from solid tumors. A 50‐year‐old man without any previous history of liver disease was diagnosed with adenocarcinoma of the left upper lung lobe and liver metastasis. After chemotherapy, the liver metastases shrank; however, over time, the liver shrank and showed cirrhosis‐like morphological changes. His performance status deteriorated due to ascites and leg edema, and chemotherapy was terminated. Physicians treating lung adenocarcinoma with liver metastases should be aware that pseudocirrhosis is a rare but important complication that can worsen performance status (PS) and hinder treatment continuation. Abstract : Liver metastasis from adenocarcinoma of the lung with abundant stromal growths showed cirrhosis‐like morphological changes in the course of treatment, ascites and marked leg edema. Pseudocirrhosis due to liver metastasis from lung adenocarcinoma is a rare but important complication that can worsen performance status and hinder treatment continuation.